243 related articles for article (PubMed ID: 36273684)
21. Primary Aldosteronism: a Continuum from Normotension to Hypertension.
Wannachalee T; Turcu AF
Curr Cardiol Rep; 2021 Jul; 23(8):105. PubMed ID: 34196827
[TBL] [Abstract][Full Text] [Related]
22. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
Kline GA; Pasieka JL; Harvey A; So B; Dias VC
Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers to Guide Medical Therapy in Primary Aldosteronism.
Hundemer GL; Leung AA; Kline GA; Brown JM; Turcu AF; Vaidya A
Endocr Rev; 2024 Jan; 45(1):69-94. PubMed ID: 37439256
[TBL] [Abstract][Full Text] [Related]
24. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
[TBL] [Abstract][Full Text] [Related]
25. Primary aldosteronism: diagnostic and therapeutic considerations.
Nishizaka MK; Calhoun DA
Curr Cardiol Rep; 2005 Nov; 7(6):412-7. PubMed ID: 16256009
[TBL] [Abstract][Full Text] [Related]
26. Advances in Medical Treatment of Primary Aldosteronism.
Li YJ; Ji ZG; Wen J
Chin Med Sci J; 2023 Mar; 38(1):49-56. PubMed ID: 36642703
[TBL] [Abstract][Full Text] [Related]
27. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.
Morimoto S; Ichihara A
Hypertens Res; 2020 Aug; 43(8):744-753. PubMed ID: 32424201
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of primary aldosteronism: an updated review.
Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
[TBL] [Abstract][Full Text] [Related]
29. Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
Tezuka Y; Turcu AF
Front Endocrinol (Lausanne); 2021; 12():625457. PubMed ID: 33841329
[TBL] [Abstract][Full Text] [Related]
30. Primary aldosteronism: Practical recommendations for treatment and follow-up.
Araujo-Castro M; Pascual-Corrales E; Martín Rojas P; Parra Ramírez P
Hipertens Riesgo Vasc; 2023; 40(4):215-221. PubMed ID: 37993292
[TBL] [Abstract][Full Text] [Related]
31. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
32. Prediction of successful outcome in patients with primary aldosteronism.
Moo TA; Zarnegar R; Duh QY
Curr Treat Options Oncol; 2007 Aug; 8(4):314-21. PubMed ID: 18058076
[TBL] [Abstract][Full Text] [Related]
33. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
34. Primary aldosteronism and pregnancy.
Morton A
Pregnancy Hypertens; 2015 Oct; 5(4):259-62. PubMed ID: 26597737
[TBL] [Abstract][Full Text] [Related]
35. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
Williams TA; Reincke M
Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
[TBL] [Abstract][Full Text] [Related]
36. Primary aldosteronism: Treatment of the disease, and new therapeutic approaches.
Funder J
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101368. PubMed ID: 31813785
[TBL] [Abstract][Full Text] [Related]
37. Malignant Hypertension and Bilateral Primary Aldosteronism.
Murai S; Kakeshita K; Imamura T; Koike T; Fujioka H; Yamazaki H; Kinugawa K
Intern Med; 2023 Sep; 62(18):2675-2680. PubMed ID: 36725041
[TBL] [Abstract][Full Text] [Related]
38. 2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism.
Ha J; Park JH; Kim KJ; Kim JH; Jung KY; Lee J; Choi JH; Lee SH; Hong N; Lim JS; Park BK; Kim JH; Jung KC; Cho J; Kim MK; Chung CH; ;
Endocrinol Metab (Seoul); 2023 Dec; 38(6):597-618. PubMed ID: 37828708
[TBL] [Abstract][Full Text] [Related]
39. Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism.
Haze T; Ozawa M; Kawano R; Haruna A; Ohki Y; Suzuki S; Kobayashi Y; Fujiwara A; Saka S; Tamura K; Hirawa N
Hypertens Res; 2023 May; 46(5):1132-1144. PubMed ID: 36754972
[TBL] [Abstract][Full Text] [Related]
40. Primary Aldosteronism: Present and Future.
Funder JW
Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
